II. MANIFESTATION OF THE ANTI-ANDROGENIC ACTION OF A STEROID ESTER TSAA-330 (16β-ETHYL-17β-HYDROXY-4-OESTREN-3-ONE CAPROATE) AND ELUCIDATION OF ITS LONG-LASTING MECHANISM USING A SIMPLE STEROID DETERMINATION TECHNIQUE

1979 ◽  
Vol 92 (3_Supplb) ◽  
pp. S24-S35 ◽  
Author(s):  
Michio Masuoka ◽  
Mutsushi Shikata ◽  
Reiko Fuziwara ◽  
Ryo Nakayama

ABSTRACT Using a simple steroid determination technique, in situ steroid absorption from a subcutaneously injected sesame oil solution in rats was pursued following the time-course changes in the steroid concentration. Based on the knowledge thus obtained, the antiandrogenic effect of a steroidal compound, TSAA-330*, could be manifested in the subcutaneous route. (1) Anti-androgenic steroid TSAA-291* and its esters in the subcutaneously injected sesame oil solution were selectively absorbed into the general circulation at different rates according to their chemical nature and structures, while the oil itself remained at the injected site for a considerably long period. At the injected site where subcutaneous doses of steroids molar equivalent to 50 mg of TSAA-291 were administered in 5 ml/rat of sesame oil, TSAA-291 decreased to the level of 10% of the initial concentration on the 4th day. TSAA-328* decreased slowly to the 50% and 20% levels on the 7th and 21st day, respectively. TSAA-335* decreased more slowly to the 50% level on the 14th day. TSAA-330 decreased most slowly only to the 70% level on the 49th day. (2) A single subcutaneous administration of 200 mg of TSAA-330 suppressed the weight increase of the accessory sex organs caused by a single subcutaneous injection of testosterone caproate (10 mg) in the immature orchiectomized rat. The suppressive effect was obvious from 2 weeks after the administration, and seemed to last for more than two weeks. The levator ani weight was not affected by the administration of TSAA-330. (3) Dose-dependent inhibitions of the accessory sex organs were obtained three weeks after a single subcutaneous administration of 50 to 400 mg of TSAA-330 in the adult male rat. (4) Daily oral administrations of 50 mg of TSAA-291 or TSAA-330 to the adult male rat for 8 days resulted in depression of the accessory sex organs to almost the same extent obtained with either agent. One week after the last administration, however, the weight of the accessory sex organs of the TSAA-291-administered animals recovered to almost the comparable level with the control, whereas a significant after-effect of the inhibition was still evident in the TSAA-330-administered animals.

1979 ◽  
Vol 92 (3_Supplb) ◽  
pp. S53-S66 ◽  
Author(s):  
Katsuichiro Sudo ◽  
Iwao Yamazaki ◽  
Michio Masuoka ◽  
Ryo Nakayama

ABSTRACT Effects of the anti-androgen TSAA-291 on the gonadotrophin secretion were studied. (1) A single subcutaneous or oral administration of TSAA-291 and its caproate induced the ovulation in the proestrous rat of which the spontaneous ovulation was blocked by the treatment with chlorpromazine. (2) A single subcutaneous administration of TSAA-291 at 2.4 mg/kg to the adult male rat induced only a slight elevation in the serum LH and FSH levels at 30 min after the administration. Successive intramuscular administrations of TSAA-291 to the adult male rat for 2 or 4 weeks resulted in significant decreases in the serum LH and FSH levels at high dose levels. A dose-dependent decrease in the serum LH level but not FSH level was observed in the orchiectomized rat. (3) Successive intramuscular adminstrations of TSAA-291 at high dose levels to the male rat suppressed the plasma testosterone level in the testicular venous blood and general circulation.


1983 ◽  
Vol 104 (2) ◽  
pp. 246-252 ◽  
Author(s):  
M. C. Viguier-Martinez ◽  
M. T. Hochereau de Reviers ◽  
B. Barenton ◽  
C. Perreau

Abstract. Adult male Wistar rats were treated with flutamide from 90 to 105 days of age. In a first experiment, testis and accessory sex organs were weighed. In the same animals, hypothalamic LRH content, pituitary gonadotrophin concentrations, plasma LH, FSH, prolactin and testosterone levels, and testicular gonadotrophin receptors were evaluated. In a second experiment, fertility was tested at the end of the treatment, and histology of the testis was performed. All the results were compared to those obtained in control animals of the same age. Accessory glands of genital tract were significantly lower in flutamide-treated animals (P < 0.01). Hypothalamic LRH, pituitary and plasma FSH, and prolactin concentrations were unchanged, while pituitary and plasma LH level and especially plasma testosterone concentration were increased (P < 0.001). Flutamide therefore exerted a strong inhibition on testosterone-dependent organs, and blocked the negative feedback of testosterone on the hypothalamo-pituitary axis, increasing the LH levels. Testis weight, intertubular tissue volume, total number and total volume of Leydig cells/testis, as well as total length and diameter of seminiferous tubules were unchanged in flutamide treated rats. However number of LH receptors/Leydig cell, nuclear area of Sertoli cells, number of FSH receptors/Sertoli cell, number of leptotene spermatocytes and of round spermatids per cross section, and yield of spermatogonial divisions were decreased after treatment. Flutamide treatment also decreased fertility by 48% (P < 0.05). This lowered fertility is likely the result of impaired spermatogenesis and/or a dysfunction of accessory sex organs.


1974 ◽  
Vol 77 (4) ◽  
pp. 636-642 ◽  
Author(s):  
H. L. Verjans ◽  
F. H. de Jong ◽  
B. A. Cooke ◽  
H. J. van der Molen ◽  
K. B. Eik-Nes

ABSTRACT The effects of subcutaneous administration of oestradiol benzoate (EB) on the weights of sex organs and on levels of testosterone and gonadotrophins in normal adult male rats have been studied. Doses of EB varied from 0.01 to 100 μg and were administered daily for seven days. Administration of 100 μg EB resulted in suppression of pituitary LH, while serum LH levels were already decreased after treatment with EB ≧ 1 μg. Pituitary and serum FSH levels were suppressed after administration of 100 and 10 μg EB respectively. Testicular tissue and serum levels of testosterone decreased after treatment with amounts of EB ≧ 1 μg. These decreased androgen levels were also reflected in a concomitant decrease in the weights of the ventral prostate and seminal vesicles. A decrease in the weight of the testes was obtained following a dose of EB ≧ 10 μg.


2014 ◽  
Vol 76 (1) ◽  
pp. 17-23 ◽  
Author(s):  
Erin K. Zinkhan ◽  
Brook Y. Lang ◽  
Baifeng Yu ◽  
Yan Wang ◽  
Chengshe Jiang ◽  
...  

2016 ◽  
Vol 258 ◽  
pp. S308-S309 ◽  
Author(s):  
M. Kemény ◽  
H.A. Marxfeld ◽  
R. Buesen ◽  
A. Chukwudebe ◽  
B. Van Ravenzwaay ◽  
...  
Keyword(s):  
Male Rat ◽  

2021 ◽  
pp. 108751
Author(s):  
Rodrigo Moraga-Amaro ◽  
Raul Díaz-Galarce ◽  
Juan P. Donoso-Ramos ◽  
Valentina Ugalde ◽  
Sergio Linsambarth ◽  
...  

2016 ◽  
Vol 46 ◽  
pp. 1573-1578 ◽  
Author(s):  
Mohammad KHALAJ-KONDORI ◽  
Farzaneh SADEGHI ◽  
Mohammad Ali HOSSEINPOURFEIZI ◽  
Farzam SHAIKHZADEH-HESARI ◽  
Aylar NAKHLBAND ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document